The IPKat

JANUARY 31, 2023

In the consequentials hearing judgment [2023] EWHC 138 , the Judge dealt with (1) royalty payments; (2) costs; (3) confidentiality; and (4) permission to appeal. Of the most interesting to this Kat was the treatment of costs (well, some of them), confidentiality and permission to appeal. The result being that money was due.

Confidentiality 52

Confidentiality Contracts Licensing Inventor 52

Trading Secrets

JULY 12, 2022

Excel alleged that Eways was a unique employee tasked with sourcing off-court marketing opportunities and endorsement deals for its athlete clients. The motion judge denied the injunction, holding that any protectable interests regarding Excel’s brand partners could be protected by more narrow non-solicitation and confidentiality provisions.

Confidentiality 52

Confidentiality Branding Brands Branding 52

IP and Legal Filings

MARCH 9, 2022

The protection of the trade secrets (the specific and confidential information about the production of the company and give the business a competitive advantage in the industry) can be legalized under major sub pars including: Patents – the protection comes with time strain. Unlike patents, trademark protection is held indefinitely.

Ownership 72

Ownership Copyright Trademark Contracts 72

azrights

APRIL 22, 2021

I stressed the importance of early IP advice in my first book, Legally Branded published in 2012, and created this animation video to highlight the significance of IP. You can safeguard your know-how, secure your contracts, or start franchising and licensing among many other things. Turning Ideas Into a Business.

IP 52

IP Intellectual Property Branding Brands 52

LexBlog IP

DECEMBER 20, 2023

The overarching goals are to stimulate a competitive data market, by allowing greater access to data and removing barriers to changing data service providers. “Customers” here includes both individual consumers and corporate entities who have entered into a contract for data processing services.

Contracts 52

Contracts Business Law Journalism 52

SpicyIP

NOVEMBER 8, 2023

In an October 2012 post, Kruttika Vijay highlighted the Supreme Court’s concerns over the lack of transparency in clinical trials in India. It bears noting, however, that confidentiality may be a valid concern and shouldn’t be just disregarded for transparency alone. Whither Clinical Trial Data?:

Trademark 59

Trademark Publishing Journalism Copyright 59

Fish & Richardson Trademark & Copyright Thoughts

FEBRUARY 4, 2021

At the same time, market uptake of biosimilars in the United States continued to increase, suggesting that there is room for expansion of biosimilars in the U.S. In addition, fewer new biosimilars entered the market this past year, with five biosimilar launches in 2020 as compared to seven in 2019. Yet biosimilars of anti-TNF?

Litigation 52

Litigation Settlement Marketing Marketing 52